Benoit Bardèche-Trystram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benoit Bardèche-Trystram has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Augustin Latourte
Université Paris Cité, AP-HP Lariboisière Hospital, Department of Rheumatology, Paris, France
1 shared publication - Caroline Andrique
Université Paris Cité, INSERM U1333 Santé Orale, et Plateforme Imagerie du Vivant (PIV), FHU-DDS-net, Dental School, Montrouge, France
1 shared publication - Eric Haÿ
Inserm BIOSCAR U1132, 2, rue Ambroise-Paré, 75010 Paris, France; Université Paris Cité, 15, rue de l'École de Médecine, 75005 Paris, France
1 shared publication Hang-Korng Ea
Bioscar UMR Inserm 1132 and Université de Paris, F-75010 Paris, France
1 shared publicationJoanna Sana
Bioscar UMR Inserm 1132 and Université de Paris, F-75010 Paris, France
1 shared publication- Martine Cohen-Solal
Department of Rheumatology and Reference Center for Rare Bone Diseases, Hospital Lariboisière, Paris, France
1 shared publication
Latest Publications
- Open Access
- 26 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (34) , eabn3106
Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice
Articular cartilage has low regenerative capacity despite permanent stress. Irreversible cartilage lesions characterize osteoarthritis (OA); this is not followed by tissue repair. Lin28a, an RNA binding protein, is detected in damaged cartilage in humans and mice. We investigated the role of LIN28a in cartilage physiology and in osteoarthritis. Lin28a-inducible conditional cartilage deletion up-regulated Mmp13 in intact mice and exacerbated the cartilage destruction in OA mice. Lin28a-specific cartilage overexpression protected mice against cartilage breakdown, stimulated chondrocyte proliferation and the expression of Prg4 and Sox9, and down-regulated Mmp13 . Lin28a overexpression inhibited Let-7b and Let-7c miRNA levels while RNA-sequencing analysis revealed five genes of transcriptional factors regulated by Let-7. Moreover, Lin28a overexpression up-regulated HMGA2 and activated SOX9 transcription, a factor required for chondrocyte reprogramming. HMGA2 siRNA knockdown inhibited the cartilage protective effect of Lin28a overexpression. This study provides insights into a new pathway including the Lin28a-Let7 axis, thus promoting chondrocyte anabolism in injured cartilage in mice.
- 26 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (34) , eabn3106
Open AccessLin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice
Articular cartilage has low regenerative capacity despite permanent stress. Irreversible cartilage lesions characterize osteoarthritis (OA); this is not followed by tissue repair. Lin28a, an RNA binding protein, is detected in damaged cartilage in humans and mice. We investigated the role of LIN28a in cartilage physiology and in osteoarthritis. Lin28a-inducible conditional cartilage deletion up-regulated Mmp13 in intact mice and exacerbated the cartilage destruction in OA mice. Lin28a-specific cartilage overexpression protected mice against cartilage breakdown, stimulated chondrocyte proliferation and the expression of Prg4 and Sox9, and down-regulated Mmp13 . Lin28a overexpression inhibited Let-7b and Let-7c miRNA levels while RNA-sequencing analysis revealed five genes of transcriptional factors regulated by Let-7. Moreover, Lin28a overexpression up-regulated HMGA2 and activated SOX9 transcription, a factor required for chondrocyte reprogramming. HMGA2 siRNA knockdown inhibited the cartilage protective effect of Lin28a overexpression. This study provides insights into a new pathway including the Lin28a-Let7 axis, thus promoting chondrocyte anabolism in injured cartilage in mice.